Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy

Nikolaus B. Wagner; Max M. Lenders; Kathrin Kühl; Lydia Reinhardt; Milena Fuchß; Natalie Ring; Ramon Stäger; Susanne Kimeswenger; Wolfram Hötzenecker; null et al.

doi:10.1016/j.ejca.2023.113425

Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy

Nikolaus B. Wagner, Max M. Lenders, Kathrin Kühl, Lydia Reinhardt, Milena Fuchß, Natalie Ring, Ramon Stäger, Susanne Kimeswenger, Wolfram Hötzenecker, et al.

Department of Dermatology and Venereology

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	113425
Number of pages	1
Journal	European Journal of Cancer
DOIs	https://doi.org/10.1016/j.ejca.2023.113425
Publication status	Published - Jan 2024

Fields of science

302087 Venereology
302011 Dermatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejca.2023.113425

Cite this

Wagner, N. B., Lenders, M. M., Kühl, K., Reinhardt, L., Fuchß, M., Ring, N., Stäger, R., Kimeswenger, S., Hötzenecker, W., & et al. (2024). Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy. European Journal of Cancer, Article 113425. https://doi.org/10.1016/j.ejca.2023.113425

@article{ac0f5190baff4acbb719be6a2635828a,

title = "Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy",

author = "Wagner, {Nikolaus B.} and Lenders, {Max M.} and Kathrin K{\"u}hl and Lydia Reinhardt and Milena Fuch{\ss} and Natalie Ring and Ramon St{\"a}ger and Susanne Kimeswenger and Wolfram H{\"o}tzenecker and {et al.}",

year = "2024",

month = jan,

doi = "10.1016/j.ejca.2023.113425",

language = "English",

journal = "European Journal of Cancer",

issn = "1879-0852",

publisher = "Elsevier",

}

TY - JOUR

T1 - Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy

AU - Wagner, Nikolaus B.

AU - Lenders, Max M.

AU - Kühl, Kathrin

AU - Reinhardt, Lydia

AU - Fuchß, Milena

AU - Ring, Natalie

AU - Stäger, Ramon

AU - Kimeswenger, Susanne

AU - Hötzenecker, Wolfram

AU - et al., null

PY - 2024/1

Y1 - 2024/1

U2 - 10.1016/j.ejca.2023.113425

DO - 10.1016/j.ejca.2023.113425

M3 - Article

SN - 1879-0852

JO - European Journal of Cancer

JF - European Journal of Cancer

M1 - 113425

ER -